A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet

NCT07184086 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: CagriSema (Cagrilintide B + semaglutide I)
BEHAVIORAL: Low Energy Diet

Sponsor

Novo Nordisk A/S